Blood pressure monitor maker Omron Healthcare has gotten approval for a new home monitor that can detect atrial fibrillation.

At the same time, the rifasutenizol regimen showed a better safety and tolerability profile than BQT. Only 3% of patients ...

The growing integration of robotic arms to enhance precision, efficiency, and safety is driving <a target=_blank href= ...

Furthermore, the ongoing Phase 3 PARADIGM study is anticipated to provide more insights ... support a firm valuation and a price target of $5 for Cybin’s stock, leading to the reiterated Buy rating.

Third-quarter results from retail giants Walmart WMT and Target TGT will be a highlight of this week’s earnings lineup. Both omnichannel retailers are expected to post sound quarterly growth with ...